1959. Ceftriaxone-Sulbactam-EDTA (CSE) vs. Meropenem (MR) in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes in Patients Infected With Ceftriaxone Non-Susceptible, Extended-Spectrum β-Lactamase and Multi-Drug-resistant Pathogens at Baseline
1959. PLEA(一项 3 期随机双盲试验)中头孢曲松-舒巴坦-EDTA (CSE) 与美罗培南 (MR) 的比较:基线时感染头孢曲松不敏感、超广谱 β-内酰胺酶和多重耐药病原体的患者的结局
期刊:Microbiome
影响因子:12.7
doi:10.1186/s40168-017-0328-9
Jeon, Soo Jin; Cunha, Federico; Vieira-Neto, Achilles; Bicalho, Rodrigo C; Lima, Svetlana; Bicalho, Marcela L; Galvão, Klibs N; Mir, Mohd Amin; Chaudhary, Saransh; Mammen, Kim Jacob; Sood, Rajeev; Dogra, P N; Chadha, Sudhir; Mavuduru, Ravimohan; Sinha, Rahul Janak; Chaudhary, Manu; Shiekh, Gazalla